CK Life Sciences International Holdings Inc
00775
Company Profile
Business description
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D. The company derives maximum revenue from the Nutraceutical segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.
Contact
2 Dai Fu Street
Tai Po Industrial Estate
Tai Po
Hong Kong
HKGT: +852 21261212
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,935
Stocks News & Analysis
stocks
Undervalued ASX share searches for cost savings
Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks
Chart of the Week: Where we see opportunities after year end market sell-off
The latest insights from our equity research team.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,951.40 | 30.00 | 0.34% |
| CAC 40 | 8,022.69 | 29.82 | -0.37% |
| DAX 40 | 24,130.14 | 32.51 | -0.13% |
| Dow JONES (US) | 48,057.75 | 497.46 | 1.05% |
| FTSE 100 | 9,655.53 | 13.52 | 0.14% |
| HKSE | 25,540.78 | 106.55 | 0.42% |
| NASDAQ | 23,654.15 | 77.67 | 0.33% |
| Nikkei 225 | 50,818.39 | 215.59 | 0.43% |
| NZX 50 Index | 13,388.15 | 17.09 | 0.13% |
| S&P 500 | 6,886.68 | 46.17 | 0.67% |
| S&P/ASX 200 | 8,658.30 | 26.80 | 0.31% |
| SSE Composite Index | 3,900.50 | 9.03 | -0.23% |